HEADER RNA BINDING PROTEIN/RNA 26-JUL-02 1M8W TITLE CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN PUMILIO1 TITLE 2 IN COMPLEX WITH NRE1-19 RNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-R(P*UP*UP*GP*UP*AP*UP*AP*U)-3'; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 5'-R(P*UP*GP*UP*AP*UP*AP*U)-3'; COMPND 7 CHAIN: D; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: 5'-R(P*UP*UP*GP*UP*CP*CP*AP*G)-3'; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: 5'-R(P*UP*GP*UP*CP*CP*AP*G)-3'; COMPND 15 CHAIN: F; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: PUMILIO 1; COMPND 19 CHAIN: A, B; COMPND 20 FRAGMENT: PUMILIO-HOMOLOGY DOMAIN, RESIDUES 828-1176; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN DROSOPHILA SOURCE 4 MELANOGASTER; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN DROSOPHILA SOURCE 8 MELANOGASTER; SOURCE 9 MOL_ID: 3; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN DROSOPHILA SOURCE 12 MELANOGASTER; SOURCE 13 MOL_ID: 4; SOURCE 14 SYNTHETIC: YES; SOURCE 15 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN DROSOPHILA SOURCE 16 MELANOGASTER; SOURCE 17 MOL_ID: 5; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 22 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 23 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 24 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 25 EXPRESSION_SYSTEM_PLASMID: PTYB3 KEYWDS PUMILIO-HOMOLOGY DOMAIN, PUF DOMAIN, NANOS RESPONSE ELEMENT, RNA KEYWDS 2 BINDING PROTEIN-RNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.WANG,J.MCLACHLAN,P.D.ZAMORE,T.M.T.HALL REVDAT 3 14-FEB-24 1M8W 1 REMARK REVDAT 2 24-FEB-09 1M8W 1 VERSN REVDAT 1 25-SEP-02 1M8W 0 JRNL AUTH X.WANG,J.MCLACHLAN,P.D.ZAMORE,T.M.T.HALL JRNL TITL MODULAR RECOGNITION OF RNA BY A HUMAN PUMILIO-HOMOLOGY JRNL TITL 2 DOMAIN JRNL REF CELL(CAMBRIDGE,MASS.) V. 110 501 2002 JRNL REFN ISSN 0092-8674 JRNL PMID 12202039 JRNL DOI 10.1016/S0092-8674(02)00873-5 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH X.WANG,P.D.ZAMORE,T.M.T.HALL REMARK 1 TITL CRYSTAL STRUCTURE OF A PUMILIO HOMOLOGY DOMAIN REMARK 1 REF MOL.CELL V. 7 855 2001 REMARK 1 REFN ISSN 1097-2765 REMARK 1 DOI 10.1016/S1097-2765(01)00229-5 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 39279 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2378 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5668 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 362 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5538 REMARK 3 NUCLEIC ACID ATOMS : 630 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 307 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.42000 REMARK 3 B22 (A**2) : 7.37000 REMARK 3 B33 (A**2) : 3.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.36000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.470 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.320 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.170 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.210 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 44.83 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : BME.PARAM REMARK 3 PARAMETER FILE 4 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1M8W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1000016742. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0093 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40790 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 42.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04200 REMARK 200 FOR THE DATA SET : 25.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.35900 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1IB3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, LITHIUM SULFATE, SODIUM REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 131.36500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.86500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 131.36500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.86500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TWO BIOLOGICAL UNITS ARE CONTAINED WITHIN AN ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, E, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, F, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CHAIN C AND E ARE ALTERNATE CONFORMATIONS OF EACH OTHER. REMARK 400 CHAIN D AND F ARE ALTERNATE CONFORMATIONS OF EACH OTHER. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 1168 REMARK 465 MET A 1169 REMARK 465 LYS A 1170 REMARK 465 ASN A 1171 REMARK 465 GLY A 1172 REMARK 465 VAL A 1173 REMARK 465 ASP A 1174 REMARK 465 LEU A 1175 REMARK 465 GLY A 1176 REMARK 465 MET B 1169 REMARK 465 LYS B 1170 REMARK 465 ASN B 1171 REMARK 465 GLY B 1172 REMARK 465 VAL B 1173 REMARK 465 ASP B 1174 REMARK 465 LEU B 1175 REMARK 465 GLY B 1176 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 843 51.32 -111.19 REMARK 500 ASN B 838 40.18 -107.31 REMARK 500 ASN B 839 73.57 34.64 REMARK 500 PRO B 946 159.05 -49.56 REMARK 500 HIS B1052 -17.16 -141.63 REMARK 500 ASP B1106 77.42 -110.55 REMARK 500 ALA B1149 -82.24 -68.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IB3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN REMARK 900 RELATED ID: 1IB2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN REMARK 900 RELATED ID: 1M8X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE1-14 RNA REMARK 900 RELATED ID: 1M8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE2-10 RNA DBREF 1M8W A 828 1176 UNP Q14671 PUM1_HUMAN 828 1176 DBREF 1M8W B 828 1176 UNP Q14671 PUM1_HUMAN 828 1176 DBREF 1M8W C 12 19 PDB 1M8W 1M8W 12 19 DBREF 1M8W D 13 19 PDB 1M8W 1M8W 13 19 DBREF 1M8W E 2 9 PDB 1M8W 1M8W 2 9 DBREF 1M8W F 3 9 PDB 1M8W 1M8W 3 9 SEQRES 1 C 8 U U G U A U A U SEQRES 1 D 7 U G U A U A U SEQRES 1 E 8 U U G U C C A G SEQRES 1 F 7 U G U C C A G SEQRES 1 A 349 GLY ARG SER ARG LEU LEU GLU ASP PHE ARG ASN ASN ARG SEQRES 2 A 349 TYR PRO ASN LEU GLN LEU ARG GLU ILE ALA GLY HIS ILE SEQRES 3 A 349 MET GLU PHE SER GLN ASP GLN HIS GLY SER ARG PHE ILE SEQRES 4 A 349 GLN LEU LYS LEU GLU ARG ALA THR PRO ALA GLU ARG GLN SEQRES 5 A 349 LEU VAL PHE ASN GLU ILE LEU GLN ALA ALA TYR GLN LEU SEQRES 6 A 349 MET VAL ASP VAL PHE GLY ASN TYR VAL ILE GLN LYS PHE SEQRES 7 A 349 PHE GLU PHE GLY SER LEU GLU GLN LYS LEU ALA LEU ALA SEQRES 8 A 349 GLU ARG ILE ARG GLY HIS VAL LEU SER LEU ALA LEU GLN SEQRES 9 A 349 MET TYR GLY CYS ARG VAL ILE GLN LYS ALA LEU GLU PHE SEQRES 10 A 349 ILE PRO SER ASP GLN GLN ASN GLU MET VAL ARG GLU LEU SEQRES 11 A 349 ASP GLY HIS VAL LEU LYS CYS VAL LYS ASP GLN ASN GLY SEQRES 12 A 349 ASN HIS VAL VAL GLN LYS CYS ILE GLU CYS VAL GLN PRO SEQRES 13 A 349 GLN SER LEU GLN PHE ILE ILE ASP ALA PHE LYS GLY GLN SEQRES 14 A 349 VAL PHE ALA LEU SER THR HIS PRO TYR GLY CYS ARG VAL SEQRES 15 A 349 ILE GLN ARG ILE LEU GLU HIS CYS LEU PRO ASP GLN THR SEQRES 16 A 349 LEU PRO ILE LEU GLU GLU LEU HIS GLN HIS THR GLU GLN SEQRES 17 A 349 LEU VAL GLN ASP GLN TYR GLY ASN TYR VAL ILE GLN HIS SEQRES 18 A 349 VAL LEU GLU HIS GLY ARG PRO GLU ASP LYS SER LYS ILE SEQRES 19 A 349 VAL ALA GLU ILE ARG GLY ASN VAL LEU VAL LEU SER GLN SEQRES 20 A 349 HIS LYS PHE ALA SER ASN VAL VAL GLU LYS CYS VAL THR SEQRES 21 A 349 HIS ALA SER ARG THR GLU ARG ALA VAL LEU ILE ASP GLU SEQRES 22 A 349 VAL CYS THR MET ASN ASP GLY PRO HIS SER ALA LEU TYR SEQRES 23 A 349 THR MET MET LYS ASP GLN TYR ALA ASN TYR VAL VAL GLN SEQRES 24 A 349 LYS MET ILE ASP VAL ALA GLU PRO GLY GLN ARG LYS ILE SEQRES 25 A 349 VAL MET HIS LYS ILE ARG PRO HIS ILE ALA THR LEU ARG SEQRES 26 A 349 LYS TYR THR TYR GLY LYS HIS ILE LEU ALA LYS LEU GLU SEQRES 27 A 349 LYS TYR TYR MET LYS ASN GLY VAL ASP LEU GLY SEQRES 1 B 349 GLY ARG SER ARG LEU LEU GLU ASP PHE ARG ASN ASN ARG SEQRES 2 B 349 TYR PRO ASN LEU GLN LEU ARG GLU ILE ALA GLY HIS ILE SEQRES 3 B 349 MET GLU PHE SER GLN ASP GLN HIS GLY SER ARG PHE ILE SEQRES 4 B 349 GLN LEU LYS LEU GLU ARG ALA THR PRO ALA GLU ARG GLN SEQRES 5 B 349 LEU VAL PHE ASN GLU ILE LEU GLN ALA ALA TYR GLN LEU SEQRES 6 B 349 MET VAL ASP VAL PHE GLY ASN TYR VAL ILE GLN LYS PHE SEQRES 7 B 349 PHE GLU PHE GLY SER LEU GLU GLN LYS LEU ALA LEU ALA SEQRES 8 B 349 GLU ARG ILE ARG GLY HIS VAL LEU SER LEU ALA LEU GLN SEQRES 9 B 349 MET TYR GLY CYS ARG VAL ILE GLN LYS ALA LEU GLU PHE SEQRES 10 B 349 ILE PRO SER ASP GLN GLN ASN GLU MET VAL ARG GLU LEU SEQRES 11 B 349 ASP GLY HIS VAL LEU LYS CYS VAL LYS ASP GLN ASN GLY SEQRES 12 B 349 ASN HIS VAL VAL GLN LYS CYS ILE GLU CYS VAL GLN PRO SEQRES 13 B 349 GLN SER LEU GLN PHE ILE ILE ASP ALA PHE LYS GLY GLN SEQRES 14 B 349 VAL PHE ALA LEU SER THR HIS PRO TYR GLY CYS ARG VAL SEQRES 15 B 349 ILE GLN ARG ILE LEU GLU HIS CYS LEU PRO ASP GLN THR SEQRES 16 B 349 LEU PRO ILE LEU GLU GLU LEU HIS GLN HIS THR GLU GLN SEQRES 17 B 349 LEU VAL GLN ASP GLN TYR GLY ASN TYR VAL ILE GLN HIS SEQRES 18 B 349 VAL LEU GLU HIS GLY ARG PRO GLU ASP LYS SER LYS ILE SEQRES 19 B 349 VAL ALA GLU ILE ARG GLY ASN VAL LEU VAL LEU SER GLN SEQRES 20 B 349 HIS LYS PHE ALA SER ASN VAL VAL GLU LYS CYS VAL THR SEQRES 21 B 349 HIS ALA SER ARG THR GLU ARG ALA VAL LEU ILE ASP GLU SEQRES 22 B 349 VAL CYS THR MET ASN ASP GLY PRO HIS SER ALA LEU TYR SEQRES 23 B 349 THR MET MET LYS ASP GLN TYR ALA ASN TYR VAL VAL GLN SEQRES 24 B 349 LYS MET ILE ASP VAL ALA GLU PRO GLY GLN ARG LYS ILE SEQRES 25 B 349 VAL MET HIS LYS ILE ARG PRO HIS ILE ALA THR LEU ARG SEQRES 26 B 349 LYS TYR THR TYR GLY LYS HIS ILE LEU ALA LYS LEU GLU SEQRES 27 B 349 LYS TYR TYR MET LYS ASN GLY VAL ASP LEU GLY FORMUL 7 HOH *307(H2 O) HELIX 1 1 SER A 830 ASN A 838 1 9 HELIX 2 2 GLN A 845 ALA A 850 5 6 HELIX 3 3 HIS A 852 GLN A 858 1 7 HELIX 4 4 ASP A 859 LEU A 870 1 12 HELIX 5 5 THR A 874 LEU A 886 1 13 HELIX 6 6 ALA A 888 VAL A 894 1 7 HELIX 7 7 GLY A 898 GLY A 909 1 12 HELIX 8 8 SER A 910 ARG A 922 1 13 HELIX 9 9 HIS A 924 LEU A 930 1 7 HELIX 10 10 TYR A 933 ILE A 945 1 13 HELIX 11 11 PRO A 946 GLU A 956 1 11 HELIX 12 12 HIS A 960 LYS A 966 1 7 HELIX 13 13 ASN A 969 VAL A 981 1 13 HELIX 14 14 GLN A 982 SER A 985 5 4 HELIX 15 15 LEU A 986 LYS A 994 1 9 HELIX 16 16 GLN A 996 THR A 1002 1 7 HELIX 17 17 TYR A 1005 CYS A 1017 1 13 HELIX 18 18 LEU A 1018 HIS A 1032 1 15 HELIX 19 19 HIS A 1032 ASP A 1039 1 8 HELIX 20 20 TYR A 1041 GLY A 1053 1 13 HELIX 21 21 ARG A 1054 ARG A 1066 1 13 HELIX 22 22 ASN A 1068 GLN A 1074 1 7 HELIX 23 23 PHE A 1077 ALA A 1089 1 13 HELIX 24 24 SER A 1090 MET A 1104 1 15 HELIX 25 25 ALA A 1111 ASP A 1118 1 8 HELIX 26 26 TYR A 1120 ALA A 1132 1 13 HELIX 27 27 GLU A 1133 ARG A 1145 1 13 HELIX 28 28 HIS A 1147 ARG A 1152 1 6 HELIX 29 29 TYR A 1156 TYR A 1167 1 12 HELIX 30 30 SER B 830 ASN B 838 1 9 HELIX 31 31 GLN B 845 ALA B 850 5 6 HELIX 32 32 HIS B 852 GLN B 858 1 7 HELIX 33 33 ASP B 859 GLU B 871 1 13 HELIX 34 34 THR B 874 LEU B 886 1 13 HELIX 35 35 ALA B 888 VAL B 894 1 7 HELIX 36 36 GLY B 898 GLY B 909 1 12 HELIX 37 37 SER B 910 ARG B 922 1 13 HELIX 38 38 HIS B 924 LEU B 930 1 7 HELIX 39 39 TYR B 933 ILE B 945 1 13 HELIX 40 40 PRO B 946 GLU B 956 1 11 HELIX 41 41 HIS B 960 LYS B 966 1 7 HELIX 42 42 ASN B 969 VAL B 981 1 13 HELIX 43 43 GLN B 982 SER B 985 5 4 HELIX 44 44 LEU B 986 PHE B 993 1 8 HELIX 45 45 GLN B 996 THR B 1002 1 7 HELIX 46 46 TYR B 1005 CYS B 1017 1 13 HELIX 47 47 LEU B 1018 GLN B 1031 1 14 HELIX 48 48 HIS B 1032 VAL B 1037 1 6 HELIX 49 49 TYR B 1041 GLY B 1053 1 13 HELIX 50 50 ARG B 1054 ARG B 1066 1 13 HELIX 51 51 ASN B 1068 GLN B 1074 1 7 HELIX 52 52 PHE B 1077 ALA B 1089 1 13 HELIX 53 53 SER B 1090 MET B 1104 1 15 HELIX 54 54 SER B 1110 LYS B 1117 1 8 HELIX 55 55 TYR B 1120 ALA B 1132 1 13 HELIX 56 56 GLU B 1133 ARG B 1145 1 13 HELIX 57 57 HIS B 1147 TYR B 1154 1 8 HELIX 58 58 GLY B 1157 GLU B 1165 1 9 SHEET 1 A 2 ASN A1105 ASP A1106 0 SHEET 2 A 2 HIS A1109 SER A1110 -1 O HIS A1109 N ASP A1106 CRYST1 262.730 37.730 82.520 90.00 102.95 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.003806 0.000000 0.000875 0.00000 SCALE2 0.000000 0.026504 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012435 0.00000